iShares U.S. Pharmaceuticals ETF Rating $67.50 -0.37 (-0.55%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$67.22 -0.28 (-0.42%) As of 06/13/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares U.S. Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IHE Aggregate RatingModerate Buy 2.66Holdings in IHE have an aggregate rating of Moderate Buy based on 336 analyst ratings issued in the past year covering 37 companies (99.8% of the portfolio).IHE Aggregate Price Target$67.50High Prediction$67.50Average Prediction$67.50Low Prediction$67.50Holdings in IHE have an aggregate price target of $67.50 and a range of $67.50 to $67.50 covering 37 companies (99.8% of the portfolio).IHE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares U.S. Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 IHE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings23.87%LLYEli Lilly and Company$818.56+0.8%4.8026 of 5 stars2.76$1,011.37 23.6%21Trending NewsAnalyst Revision23.13%JNJJohnson & Johnson$156.90+0.2%4.765 of 5 stars2.55$170.88 8.9%20Trending News5.03%RPRXRoyalty Pharma$34.84-1.2%4.7245 of 5 stars3.25$47.33 35.9%4Positive NewsShort Interest ↑4.99%ZTSZoetis$164.27-2.7%4.6443 of 5 stars3.10$212.75 29.5%10Positive NewsGap Down4.72%VTRSViatris$8.92-1.9%2.5372 of 5 stars1.80$10.40 16.6%54.62%PFEPfizer$24.51-1.3%4.974 of 5 stars2.53$29.17 19.0%15Trending NewsAnalyst Revision4.18%MRKMerck & Co., Inc.$81.68-0.2%4.9964 of 5 stars2.43$109.19 33.7%21Positive NewsAnalyst Revision4.07%BMYBristol-Myers Squibb$49.71-1.9%4.8453 of 5 stars2.32$58.00 16.7%22Positive NewsAnalyst Revision3.15%ELANElanco Animal Health$13.82-2.5%1.0295 of 5 stars2.43$15.17 9.7%7Gap Down2.98%JAZZJazz Pharmaceuticals$108.50-1.6%4.9617 of 5 stars2.92$184.00 69.6%13Analyst Forecast2.96%CORTCorcept Therapeutics$70.06-1.6%4.6441 of 5 stars3.00$138.25 97.3%5News CoverageInsider Trade1.96%AXSMAxsome Therapeutics$104.10-2.0%4.6819 of 5 stars3.06$172.33 65.5%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.88%PBHPrestige Consumer Healthcare$83.84-1.5%4.1208 of 5 stars2.50$93.33 11.3%6Positive News1.67%PRGOPerrigo$26.66-2.2%4.5761 of 5 stars2.25$33.00 23.8%4Positive News1.16%OGNOrganon & Co.$10.03-0.4%4.7766 of 5 stars2.50$18.00 79.6%6Trending News0.97%LGNDLigand Pharmaceuticals$112.50-1.7%4.3938 of 5 stars3.00$146.14 29.9%7News CoveragePositive News0.82%SUPNSupernus Pharmaceuticals$32.03-2.3%2.1624 of 5 stars2.33$36.00 12.4%3Positive News0.64%TARSTarsus Pharmaceuticals$40.89-0.1%2.1236 of 5 stars3.00$66.67 63.0%7Positive News0.60%HRMYHarmony Biosciences$32.97-1.1%4.767 of 5 stars3.11$53.00 60.8%9Positive NewsShort Interest ↑Analyst Revision0.52%AMRXAmneal Pharmaceuticals$7.75-2.6%3.5743 of 5 stars3.00$11.60 49.7%5Positive News0.52%INVAInnoviva$21.69+1.4%4.1144 of 5 stars3.00$55.00 153.6%2High Trading Volume0.50%PCRXPacira BioSciences$24.24-0.9%2.457 of 5 stars2.33$26.44 9.1%9Positive News0.50%OCULOcular Therapeutix$8.73-2.5%3.7874 of 5 stars2.88$16.25 86.1%8Positive News0.49%EWTXEdgewise Therapeutics$15.29-0.8%2.6453 of 5 stars2.78$39.78 160.2%9Gap Up0.46%ANIPANI Pharmaceuticals$62.56+0.7%4.1678 of 5 stars3.00$80.13 28.1%9Positive News0.44%AMPHAmphastar Pharmaceuticals$25.82-2.3%4.2378 of 5 stars2.25$32.33 25.2%40.43%COLLCollegium Pharmaceutical$29.18-1.4%3.9936 of 5 stars2.75$43.75 49.9%4Insider Trade0.43%HROWHarrow$30.31-2.7%2.3521 of 5 stars3.00$61.40 102.6%6News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGap Up0.38%WVEWave Life Sciences$6.95-3.5%4.2523 of 5 stars2.92$20.50 195.0%12News CoverageAnalyst ForecastInsider TradeAnalyst RevisionGap Down0.30%LQDALiquidia$14.10-2.4%3.6927 of 5 stars3.00$26.89 90.7%9Analyst ForecastOptions Volume0.26%ELVNEnliven Therapeutics$21.91+11.4%2.4707 of 5 stars3.00$37.25 70.0%4News CoverageInsider TradeGap DownHigh Trading Volume0.25%NUVBNuvation Bio$1.73-4.7%2.9497 of 5 stars3.17$7.83 354.1%6News CoverageAnalyst ForecastHigh Trading Volume0.23%EOLSEvolus$9.93-2.5%4.0542 of 5 stars3.00$23.75 139.2%5Positive NewsInsider Trade0.22%MNMDMind Medicine (MindMed)$7.17-1.8%1.9209 of 5 stars3.27$25.50 255.6%11Positive NewsAnalyst RevisionGap Down0.22%ARVNArvinas$7.39-2.4%3.7724 of 5 stars2.55$20.29 174.6%22Analyst RevisionGap Down0.17%TBPHTheravance Biopharma$10.69+0.8%0.8648 of 5 stars2.25$11.33 6.0%4Positive News0.09%OMEROmeros$3.40-4.2%3.6885 of 5 stars2.83$18.00 429.4%6Trending NewsAnalyst ForecastAnalyst Revision This page (NYSEARCA:IHE) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IHE Stock Free IHE Stock Alerts